Tag Archives: WebMD

With growing public awareness of antidepressant risks: Pro-pill website Web MD does damage control

There was a day when it seemed like everyone was on antidepressant “happy pills” like Prozac, Paxil and Zoloft. But then the pendulum began to swing. Patients objected to the weight gain and feelings of not being “themselves,” sexual side effects and the withdrawal symptoms. There were even reports and warnings about suicide and other “neuropsychiatric” effects.

Now, WebMD, the gigantic, pro-pill web site whose original partner was Eli Lilly, is doing damage control for SSRI antidepressants. New articles, sounding like they’re from crib makers or cantaloupe growers, urge patients not to panic or quit taking their pills just because of things they read.

Selling Depression—Adding New Spin and Urgency to Depression Drug Sales

The discovery that many people with life problem or occasional bad moods would willingly dose themselves with antidepressants sailed the drug industry through the 2000s. A good chunk of the $4.5 billion a year direct-to-consumer advertising has been devoted to convincing people they don’t have problems with their job, the economy and their family, they have depression. Especially because depression can’t be diagnosed from a blood test.

Unfortunately, three things dried up the depression gravy train for the drug industry. Blockbusters went off patent and generics took off, antidepressants were linked with gory and unpredictable violence, especially in young users and — they didn’t even work, according to medical articles!

Oh That? Seroquel Marketing Undeterred by This Week’s Deceptive Marketing Settlement

Google the word “depression” and the first search result you’ll get is for the antipsychotic Seroquel XR. Visit WebMD and the home page hosts similar ads for Seroquel XR, above and adjacent to the lead news story. Who would know AstraZeneca inked the largest multi-state consumer protection settlement on record relating to deceptive Seroquel marketing just this week? For $68.5 million? Only a year after inking a similar settlement related to burying side effect and safety information for $520 million with the government? Who would know AstraZeneca has already settled nearly 25,000 personal injury lawsuits pertaining to Seroquel with more to come says ABC news?

First approved in 1997, Seroquel has enjoyed the camel-nose-under-the-tent phenomenon known as indications creep. First approved for schizophrenia, it was later approved for bipolar disorder and psychiatric conditions in children. But it was Seroquel’s 2009 approval as an add-drug for depression that helped it reach its spectacular sales of $5.3 billion in 2010 thanks to the US’ walloping depression “market” of 20 million.